As of January 23, 2025, VYNE Therapeutics (VYNE) has a market cap of $40.124 million USD. According to our data, VYNE Therapeutics is ranked No.8279 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $40.12 M |
-18.81%
|
Dec 31, 2024 | $49.42 M |
43.78%
|
Dec 29, 2023 | $34.37 M |
-13.70%
|
Dec 30, 2022 | $39.83 M |
-85.29%
|
Dec 31, 2021 | $0.27 B |
-83.86%
|
Dec 31, 2020 | $1.68 B |
-65.95%
|
Dec 31, 2019 | $4.93 B |
12.62%
|
Dec 31, 2018 | $4.38 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novo Nordisk A/S
NOVO-B.CO
|
$364.81 B |
95.450 B
|
Denmark
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Roche
ROG.SW
|
$243.84 B |
38.062 B
|
Switzerland
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
CSL
CSL.AX
|
$82.07 B |
-0.055 B
|
Australia
|
Zoetis
ZTS
|
$75.18 B |
-0.001 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Chugai Pharmaceutical
4519.T
|
$68.91 B |
-0.695 B
|
Japan
|
Market Cap | = | VYNE Stock Price | * | VYNE Shares Outstanding |
= | $2.72 | * | 14.75 M | |
= | $40.12 M |